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sing two-hybrid screening, we isolated the integrin
cytoplasmic domain-associated protein (ICAP-1),
an interactor for the COOH terminal region of the
 
 
 
1A integrin cytoplasmic domain. To investigate the role of
ICAP-1 in integrin-mediated adhesive function, we expressed
the full-length molecule in NIH3T3 cells. ICAP-1 expression
strongly prevents NIH3T3 cell spreading on extracellular
matrix. This inhibition is transient and can be counteracted
by coexpression of a constitutively activated mutant of
Cdc42, suggesting that ICAP-1 acts upstream of this GTPase.
In addition, we found that ICAP-1 binds both to Cdc42 and
U
 
Rac1 in vitro, and its expression markedly inhibits activation
of these GTPases during integrin-mediated cell adhesion to
ﬁbronectin as detected by PAK binding assay. In the attempt
to deﬁne the molecular mechanism of this inhibition, we
show that ICAP-1 reduces both the intrinsic and the exchange
factor–induced dissociation of GDP from Cdc42; moreover,
puriﬁed ICAP-1 displaces this GTPase from cellular mem-
branes. Together, these data show for the ﬁrst time that ICAP-1
regulates Rho family GTPases during integrin-mediated cell
matrix adhesion, acting as guanine dissociation inhibitor.
 
Introduction
 
Rho family GTPases are cytoplasmic proteins controlling
several crucial cellular functions such as organization of the
cytoskeleton in cell motility, gene expression, and cell cycle
progression. Three of these GTPases, Cdc42, Rac1, and
RhoA, have been studied in some detail and shown to play a
major role in regulating actin cytoskeleton in response to
soluble extracellular stimuli known to induce cell motility,
such as PDGF and lysophosphatidic acid (LPA)* (Nobes
and Hall, 1995; Hall, 1998). In particular Cdc42 and Rac1
regulate the ability of the cell to elongate membrane protru-
sions, such as filopodia and lamellipodia, whereas RhoA
controls the organization of actin in stress fibers (Hall,
1998) ending at “focal adhesions,” sites of cell matrix con-
tact where integrins are clustered.
Filopodia, lamellipodia, and stress fibers are also formed
during integrin-mediated cell adhesion to and spreading on
insoluble extracellular matrix proteins in the absence of soluble
motogenic factors. Integrins are major membrane receptors
involved in cell matrix adhesion that generate a cascade
of intracellular signals, leading to the organization of the
actomyosin filaments (Schoenwaelder and Burridge, 1999;
Schwartz and Shattil, 2000). Analysis of such signals indicated
that integrins can trigger activation of Rho family GTPases
(Clark et al., 1998; Price et al., 1998; Olivo et al., 2000). In
particular, it has been shown that integrins can activate
p21PAK and ACK2, two known effectors of Cdc42 and
Rac1, very shortly after binding to fibronectin (Price et al.,
1998; Yang et al., 1999). Activation of these effectors is
inhibited by expression of a dominant negative form of
Cdc42 (Price et al., 1998; Yang et al., 1999), which also
strongly inhibited cell spreading (Clark et al., 1998; Price et
al., 1998; Olivo et al., 2000). On the other hand, only modest
effect on cell spreading was observed with Rac1 dominant
negative mutants or by inhibiting RhoA with C3 exoenzyme
(Clark et al., 1998; Price et al., 1998; Olivo et al., 2000).
 
Address correspondence to Guido Tarone, Dept. of Genetics, Biology,
and Biochemistry, University of Torino, Via Santena 5 bis, 10126
Torino, Italy. Tel.: 39-011-670-6679. Fax: 39-011-670-6547. E-mail:
guido.tarone@unito.it
S. Degani and F. Balzac contributed equally to this work.
 
*Abbreviations used in this paper: DH, Dbl homology; GAP, GTPase-
activating protein; GDI, guanine nucleotide dissociation inhibitor; GEF,
guanine nucleotide exchange factor; ICAP, integrin cytoplasmic domain-
associated protein; LPA, lysophosphatidic acid; PH, pleckstrin homology.
Key words: integrins; Cdc42; Rac; ICAP-1; GDI; cytoskeleton 
378 The Journal of Cell Biology 
 
|
 
 
 
Volume 156, Number 2, 2002
 
These data clearly indicate that activation of Cdc42 is crucial
for integrin-mediated cell spreading on matrix proteins. How-
ever, the molecular mechanisms leading to regulation of
Cdc42 upon integrin binding to their ligands are still poorly
defined.
Activation of monomeric GTPases is determined by cy-
cling between the GDP- and GTP-bound states. This pro-
cess is controlled by three major classes of molecules known
as guanine nucleotide exchange factors (GEFs), GTPase-
activating proteins (GAPs), and guanine nucleotide dissocia-
tion inhibitors (GDIs) (Van Aelst and D’Souza-Schorey,
1997). GEFs induce the exchange of GDP for GTP, thus
promoting the activation of the GTPases. Over 30 different
GEFs have been described, all of which contain a Dbl ho-
mology (DH) domain flanked at the COOH-terminal by a
pleckstrin homology (PH) domain (Hart et al., 1994). Al-
though the DH domain is responsible for the GEF catalytic
activity, the PH domain localizes the GEF protein to the
plasma membrane where their GTPase substrates reside.
Numerous GAPs have also been identified, which increase
the intrinsic rate of GTP hydrolysis of the GTPase, thus
promoting the transition to the inactive GDP-bound state.
The third class of GTPase regulators is represented by the
GDIs. Only a few of these proteins have been identified to
date, and their structure has been solved recently. GDIs
form a complex with GTPases sequestering these molecules
in the cytoplasm and preventing their membrane association
(Leonard et al., 1992). The formation of this complex is me-
diated by the COOH-terminal region of the GDI molecule,
which forms a hydrophobic pocket accommodating the GTP-
ase-bound isoprenyl lipid necessary for membrane localiza-
tion, of the GTPase (Gosser et al., 1997; Keep et al., 1997;
Hoffman et al., 2000; Scheffzek et al., 2000). The NH
 
2
 
-ter-
minal region of the GDI molecule consists of a flexible arm
capable of inhibiting GDP dissociation by binding to the
switch I and II domains of the GTPase (Keep et al., 1997;
Hoffman et al., 2000; Scheffzek et al., 2000).Thus, activa-
tion of a Rho family GTPase likely involves activation of
GEFs and the simultaneous inhibition of GDIs and/or
GAPs.
Using the two-hybrid system, we identified a group of
proteins capable of binding to the cytoplasmic domain of
 
 
 
1-integrin (Brancaccio et al., 1999). Among these, we iso-
lated the integrin cytoplasmic domain associated protein
(ICAP-1), which was also isolated by other laboratories us-
ing similar baits but different cDNA libraries (Chang et al.,
1997; Zhang and Hemler, 1999). The data presented here
show that overexpression of ICAP-1 strongly reduces the in-
tegrin-mediated cell spreading on extracellular matrix and
inhibits both Cdc42 and Rac1. In addition, ICAP-1 induces
release of Cdc42 from cellular membranes and prevents the
dissociation of GDP from this GTPase. Thus, ICAP-1 is a
new GTPase regulatory protein endowed with GDI activity
and involved in the integrin-mediated actin cytoskeleton
regulation during cell matrix adhesion.
 
Results
 
Isolation of ICAP-1 by two-hybrid screening 
and binding specificity
 
To identify proteins able to interact with the 
 
 
 
1-integrin cy-
toplasmic domain, we performed an interaction trap ap-
proach (Gyuris et al., 1993). Using the entire 
 
 
 
1A cytoplas-
mic region as a bait to screen a cDNA heart neonatal rat
library, we isolated three different proteins (Brancaccio et
al., 1999). One of these proteins was found to be the inte-
grin cytoplasmic domain-associated protein, ICAP-1, iso-
lated recently also in other laboratories by screening of dif-
ferent cDNA libraries (Chang et al., 1997; Zhang and
Hemler, 1999). ICAP-1 was found to specifically bind to
 
 
 
1-integrin but not to 
 
 
 
2, 
 
 
 
3, and 
 
 
 
5. In addition, no
binding was observed with the 
 
 
 
1B and 
 
 
 
1D isoforms,
which differ from 
 
 
 
1A in the COOH terminus of the pro-
tein (Balzac et al., 1994; Belkin et al., 1996; Table I). To
map the amino acid sequences of 
 
 
 
1 required for binding to
ICAP-1, swapping mutants were generated between the 
 
 
 
1A
and 
 
 
 
1D molecules and tested in the two-hybrid system.
The results of these experiments indicate that, although im-
portant, the NPXY sequences alone (Chang et al., 1997) are
not sufficient for ICAP-1 binding (bait 
 
 
 
1A/D/A in Table
I). In fact, the six amino acid region AVTTVV (878–884) of
 
 
 
1A located between the two NPXY motives is required for
ICAP-1 binding (bait 
 
 
 
1D/A/D in Table I).
 
ICAP-1 inhibits the initial phase of cell spreading
 
To test the possible function of ICAP-1, we transiently
transfected this molecule in NIH3T3 cells. As detected with
 
Table I. 
 
Binding of ICAP-1 to different integrin subunit cytopasmic domain constructs
 Bait sequences ICAP-1
 
a
 
 binding
 
 
 
1A KLLMIIHDRREFAKFEKEKMNAKWDT
 
GENPIYKSAVTTVVNPKYEGK
 
   
 
 
1D KLLMIIHDRREFAKFEKEKMNAKWDTQENPIYKSPINNFKNPNYGRKAGL
 
 
 
 
1A/D KLLMIIHDRREFAKFEKEKMNAKWDT
 
GENPIYKSAVTTVVNPKY
 
GRKAGL
 
   
 
 
1D/A/D KLLMIIHDRREFAKFEKEKMNAKWDTQENPIYKS
 
AVTTVV
 
NPNYGRKAGL
 
  
 
 
1A/D/A KLLMIIHDRREFAKFEKEKMNAKWDT
 
GENPIYKS
 
PINNFK
 
NPKYEGK
 
 
 
 
1D/A KLLMIIHDRREFAKFEKEKMNAKWDTQENPIYKSPINNFKNPNY
 
EGK
 
 
 
 
1B KLLMIIHDRREFAKFEKEKMNAKWDTSYKTSKKQSGL
 
 
 
 
2 KALIHLSDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES
 
 
 
 
3 KLLITIHDRKEFAKFEEERARAKWDTVRDGAGRFLKSLV
 
 
 
 
5 KLGFFKRSLPYGTAMEKAQLQPPATSDA
 
 
 
The bolded sequences are specific to the 
 
 
 
1A variable region.
 
a
 
Number of 
 
  
 
indicates the strength of the interaction judged by intensity of blue after growing colonies on X-gal indicator plates lacking leucine. 
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our polyclonal antibody, the endogenous level of ICAP-1
was very low in these cells and raised 
 
 
 
20 times after trans-
fection. Transfected cells were detached from the dish and
replated on fibronectin-coated glass to test their ability to
adhere and spread. As shown in Fig. 1, cells expressing
ICAP-1 attach to fibronectin, but only 35% 
 
 
 
 6 spread af-
ter 60 min of plating on the coated substratum, whereas
84% 
 
 
 
 4 of control untransfected cells present in the same
sample spread under the same plating conditions. The inhi-
bition of cell spreading by ICAP-1 expression was not the re-
sult of a toxic or non specific effect, since cells recover from
inhibition and spread normally after overnight incubation
Figure 1. ICAP-1 inhibition of cell spreading and rescue by 
V12Cdc42. Cells were transiently transfected, detached with EDTA, 
plated on fibronectin-coated coverslips (5  g/ml) in serum-free 
medium, fixed, and stained with different antibodies. (A) NIH3T3 
cells transfected with myc–ICAP-1 and plated on fibronectin for 1 h 
(a) and for 24 h (b). NIH3T3 cotransfected with myc–ICAP-1 and 
myc-V12Cdc42 plated for 1 h on fibronectin (c). V12Cdc42-NIH3T3 
transiently transfected with myc–ICAP-1 and plated for 1 h on 
fibronectin (d). Transfected cells were visualized by anti-myc 
monoclonal antibody (left), whereas actin organization was 
detected in the same sample with FITC phalloidin (right). (B) The 
percentage of spread cells was calculated as described in Materials 
and methods. Values are means   SD from three independent 
experiments in which  20 cells per condition were scored. 
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1 h of adhesion. This ICAP-1 inhibitory effect was compara-
ble to that observed on fibronectin (Fig. 1, A and B, com-
pared with Fig. 2, A and B). Taken together, these results
suggest that in our experimental condition ICAP-1 effect
seems not to be dependent on integrin binding.
 
ICAP-1 inhibition of cell spreading is reversed by an 
activated form of Cdc42
 
Rho family GTPases regulate the actin organization required
for cell adhesion and migration (Nobes and Hall, 1999).
Previous work has shown that transient expression of a
Cdc42 dominant negative mutant strongly inhibits cell
spreading during adhesion on extracellular matrix (Clark et
al., 1998; Price et al., 1998; Olivo et al., 2000). The fact
that expression of ICAP-1 and a dominant negative form of
Cdc42 induce a similar phenotype raises the possibility that
the two proteins act on the same pathway. To test this hy-
pothesis, we cotransfected ICAP-1 with the constitutively
activated form of Cdc42, V12Cdc42. As shown in Fig. 1,
ICAP-1 induced only a modest inhibitions of cell spreading
in cells transiently transfected with V12Cdc42. Similar re-
sults were observed in cells stably expressing V12Cdc42
(Fig. 1). In these cells, ICAP-1 induced a 1.8–2.7-fold de-
crease of cell spreading, whereas in control cells it induced
much strong response (4-fold decrease; Fig. 1 B). These re-
sults suggest that Cdc42 acts downstream of ICAP-1 during
cell spreading on extracellular matrix.
 
ICAP-1 binds and inhibits Cdc42 and Rac1
 
Based on the results described above, we tested the possibil-
ity that ICAP-1 could regulate the activity of Rho family
GTPases. To measure the activation state of Cdc42 and
Rac1, the GTP-bound form of these proteins was isolated
using the CRIB domain of the effector protein PAK (Sander
et al., 1998). Cells transfected with control vector or ICAP-1
were either maintained in suspension or plated on fibronec-
tin, and cell extracts were processed as described in Materials
and methods. COS cells were used in these experiments in
order to achieve high level of expression. As shown in Fig. 3
A and Fig. 4 A, the amount of GTP-bound GTPases is in-
creased upon cell adhesion to fibronectin, indicating that
both Cdc42 and Rac1 are activated during cell spreading on
fibronectin. However, expression of ICAP-1 in these cells
strongly reduced the level of GTP-bound form of both GTP-
ases (Fig. 3 and Fig. 4, A and B).
In the experimental condition used to analyze the activa-
tion level of Cdc42 and Rac1 during cell spreading, we were
not able to detect any significant activation of RhoA, as
measured by pull-down assay with the Rho effector protein
mDia (Kimura et al., 2000), in accordance with previous re-
ports (Ren et al., 1999; Arthur et al., 2000). Given that the
adhesive stimulus was not sufficient to induce RhoA activa-
tion, we then activated RhoA by either treating COS cells
with LPA or transfecting them with pCEFL-GST-DH/PH
coding for a GST fusion protein containing the DH/PH do-
mains of the GEF protein Dbl. However, in both of these
conditions ICAP-1 expression did not affect RhoA activity
(unpublished data; Fig. 5 A).
To better understand the inhibitory action of ICAP-1
on Cdc42 and Rac1, we performed affinity chromatogra-
Figure 2. ICAP-1 inhibition of cell spreading on vitronectin. (A) 
NIH3T3 cells were transiently transfected with myc–ICAP-1, 
detached with EDTA, and allowed to attach on vitronectin-coated 
coverslips (10  g/ml) in serum-free medium for 1 h. Transfected 
cells were visualized by anti-myc monoclonal antibody, whereas 
actin organization was detected in the same sample with FITC 
phalloidin. (B) The percentage of spread cells was calculated as 
described in Materials and methods. Values are means   SD from 
three independent experiments in which  20 cells per condition 
were scored.
 
on fibronectin (Fig. 1 A, b). Moreover, expression of a dif-
ferent 
 
 
 
1 integrin interactor, such as melusin (Brancaccio et
al., 1999), did not alter cell adhesion or spreading (unpub-
lished data).
Interestingly, ICAP-1 effect can be appreciated only when
cells were detached and replated on fibronectin. In fact,
transient transfection of cell monolayer or microinjection of
adherent cells with ICAP-1 constructs did not significantly
alter the cell morphology (unpublished data). These data
show that inhibition of cell spreading by ICAP-1 is specific
and occurs only when cells are replated on fibronectin, sug-
gesting a crucial role of ICAP-1 during the initial phases of
cell–matrix interaction.
Given that ICAP-1 binds to 
 
 
 
1
 
A but not to 
 
 
 
3
 
 and 
 
 
 
5
 
 in-
tegrin subunits (unpublished data; Chang et al., 1997), we
wondered whether the ICAP-1 antispreading effect was de-
pendent on integrin 
 
 
 
1
 
A binding. To this purpose, we ana-
lyzed spreading of ICAP-1–expressing NIH3T3 cells on vi-
tronectin, a substrate for 
 
 
 
V
 
 
 
3
 
 and 
 
 
 
v
 
 
 
5
 
. As shown in Fig. 2,
ICAP-1–expressing cells spread poorly on vitronectin after 
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phy experiments to test the ability of these proteins to in-
teract with each other. COS cell extracts were incubated
with Sepharose coupled to purified MBP–ICAP-1 fusion
protein. As shown in Fig. 3 C and Fig. 4 C, Cdc42 and
Rac1 bind to MBP–ICAP-1 but not to MBP carrier pro-
tein.
On the other hand, affinity chromatography experi-
ments showed that RhoA did not appreciably bind to
Figure 3. ICAP-1 inhibits and binds 
Cdc42. (A) COS cells transiently 
transfected with myc-Cdc42 together 
with control vector or myc–ICAP-1 were 
suspended by trypsin treatment, kept in 
suspension 2 h 30 min in serum-free 
DME (Su), and plated on fibronectin (5 
 g/ml) for 1 h (Ad). Cdc42 activity assay 
was performed as described in Materials 
and methods using a GST-PAK-CD 
fusion protein that selectively binds to 
GTP-Cdc42. The bound GTP-Cdc42 was 
analyzed by Western blotting with a 
polyclonal antibody to Cdc42. To probe 
for Cdc42 and ICAP-1 expression, total 
cell lysates were blotted with the corre-
sponding antibodies. (B) The amount of 
GTP-bound and total Cdc42 (A, bottom 
band of the doublets) was quantified by 
densitometric analysis, and the activa-
tion level of Cdc42 was expressed as a 
ratio between the values of GTP-bound 
and total Cdc42. Comparable results 
were obtained in three independent 
experiments. (C) Total protein extract of COS cells transfected with GST-Cdc42 was loaded on Sepharose coupled with MBP–ICAP-1 fusion 
protein or MBP as control. The proteins eluted with glycine-HCl, pH 3.0, buffer (fractions numbers 1-2-3-4) were analyzed by Western blot-
ting with polyclonal antibody against Cdc42. Note that in A, Cdc42 is detected as a doublet of bands; comparison of the electrophoretic 
mobility indicates that the bottom band of the doublet in A comigrates with the band in C. The top band of the doublet is likely to represent 
an incompletely processed form of the GTPase. (D) Western blotting with an antibody against Cdc42 of the pooled fractions eluted from 
MBP–ICAP-1-Sepharose columns (right). The columns were loaded with equal amounts of GST-Cdc42 fusion protein obtained from either 
the membrane fraction of pCEFL-GST-Cdc42–transfected COS cells (a), the cytoplasmic fraction of the same cells (b), or bacterial lysate of 
E. coli producing the GST-Cdc42 fusion protein (c). The amount of fusion proteins loaded on the column are shown on the left as control for 
equal loading.
Figure 4. ICAP-1 inhibits and binds Rac1. (A) COS cells transiently 
transfected with control vector or myc–ICAP-1 were suspended by 
trypsin treatment, kept in suspension 2 h 30 min in serum-free DME 
(Su), and plated on fibronectin (5  g/ml) for 1 h (Ad). Rac1 activation 
level was evaluated as described in Materials and methods using a 
GST-PAK-CD fusion protein that selectively binds to GTP-Rac1. The 
bound GTP-Rac1 was analyzed by Western blotting with a polyclonal 
antibody to Rac1. To probe for Rac1 and ICAP-1 expression, total 
cell lysates were blotted with the corresponding antibodies. (B) The 
amount of GTP-bound and total Rac1 (A) was quantified by densito-
metric analysis; the activation level of Rac1 is expressed as a ratio 
between the values of GTP-bound and total Rac1. Comparable 
results were obtained in three independent experiments. (C) Total 
lysate of COS cells transfected with myc-Rac1 was loaded on 
Sepharose coupled with MBP–ICAP-1 fusion protein or MBP as 
control. The proteins eluted with glycine-HCl, pH 3, buffer 
(fractions numbers 1-2-3-4) were analyzed by Western blotting 
with a monoclonal antibody against Rac1. 
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MBP–ICAP-1 (Fig. 5 B). Moreover, we tested the bind-
ing of transfected molecules unrelated to GTPases, such
as melusin (Brancaccio et al., 1999), or endogenous COS
proteins such as p125Fak and paxillin. None of these
proteins bind to ICAP-1 (unpublished data), demonstrat-
ing the specificity of the interaction with Cdc42 and
Rac1 GTPases.
Rho family GTPases are posttranslationally modified in
eukaryotic cells by covalent binding of an isoprenyl chain
that allows association with cellular membranes to exert
Figure 5. ICAP-1 does neither inhibit nor bind RhoA. 
(A) RhoA activity assay was performed as described in 
Materials and methods using COS cells either untrans-
fected or transfected as indicated. The same blot was 
reprobed for ICAP-1 expression with a polyclonal 
antibody against ICAP-1. (B) Total protein extract of 
COS cells was loaded on Sepharose coupled with 
MBP–ICAP-1 fusion protein or MBP as control. The 
eluted proteins were analyzed by Western blotting 
with a monoclonal antibody against RhoA. The same 
filter was stripped and tested for the presence of Rac1 
using a specific monoclonal antibody (B’). Total 
extract is shown as control.
Figure 6. Inhibitory effect of ICAP-1 on the dissociation of 
[ -
32P]GDP from Cdc42. GST-Cdc42 was expressed in COS cells, 
and the protein was purified from the membranous fraction and 
captured on glutathione-Sepharose. The Cdc42 immobilized on the 
beads was loaded with guanosine nucleotide by incubation with 
[ -
32P]GTP 25 min at room temperature. The dissociation of the 
GDP induced by chelating Mg
2  with EDTA (A) or by the GEF activ-
ity of Dbl (B) was measured in the presence of either the buffer alone, 
MBP–ICAP-1(10  g), or the same amount of GST-Rho GDI fusion 
proteins after 10 min at room temperature. (C) Time course for 
[ -
32P]GDP dissociation from Cdc42 induced by chelating Mg
2  
with EDTA in the presence of either 10  g of MBP–ICAP-1, GST-Rho GDI, MBP carrier protein, or buffer alone. Results shown are means   SD 
of values from three experiments. [ -
32P]GDP remaining is expressed as the percentage of [ -
32P]GDP bound to Cdc42 after loading. 
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their biological activity. To test whether this modification
affects binding to ICAP-1, Cdc42-containing extracts were
prepared from membrane and cytosol fractions of COS and
prokaryotic cells. Maximal binding was observed for Cdc42
extracted from the membrane fraction, whereas binding of
Cdc42 from prokaryotic cells was eightfold less efficient,
suggesting that isoprenylation is important for this interac-
tion (Fig. 3 D). In addition, the reduced binding of cytosolic
Cdc42 to ICAP-1 compared with the membrane Cdc42
fraction is likely due to a preferential binding of cytoplasmic
Cdc42 to endogenous Rho-GDI.
In addition we found that ICAP-1 binds with similar inten-
sity to the GTP or GDP form of Cdc42 (unpublished data).
 
ICAP-1 inhibits GDP dissociation
 
GAPs and GDIs are important negative regulators of mono-
meric GTPases. Comparative sequence analysis indicated
a partial degree of homology between ICAP-1 and known
GDI molecules (see Fig. 8 and Discussion). To test whether
ICAP-1 can exert GDI activity, Cdc42 was expressed in COS
cells as a GST fusion protein, and the membrane-bound frac-
tion was affinity purified. After loading of Cdc42 with radio-
active GTP, the release of the nucleotide induced either by
chelating Mg
 
2
 
 
 
 ions or by the Dbl GEF was measured in the
presence of purified ICAP-1, unrelated molecule, such as the
carrier protein MBP, or a known GDI such as RhoGDI. As
shown in Fig. 6, ICAP-1 inhibits the dissociation of GDP in-
duced either by EDTA (see Fig. 6 A) or by Dbl GEF (see Fig.
6 B). MBP control protein does not alter the release of GDP
with respect to buffer control (see Fig. 6 C).
A known activity of GDIs is their ability to induce the re-
lease of the GTPase from cellular membranes (Leonard et
al., 1992). To test for this activity, membrane fractions from
COS cells transfected with Cdc42 constructs were incubated
with purified MBP–ICAP-1 fusion protein or MBP alone.
As shown in Fig. 7, increasing amounts of purified ICAP-1
caused an increasing level of Cdc42 to be released into a sol-
uble supernatant fraction. The result demonstrates that
ICAP-1, besides being able to inhibit GDP dissociation, is
also able to specifically elicit the release of Cdc42 from the
membrane.
 
Discussion
 
Here we report that ICAP-1, a protein which binds to the
 
 
 
1 integrin cytoplasmic domain, inhibits cell spreading on
extracellular matrix substratum by interfering with Cdc42
and Rac1 activation.
Hemler and coworkers have shown that ICAP-1 can pro-
mote 
 
 
 
1-integrin–dependent cell migration (Zhang and
Hemler, 1999). These authors have not analyzed the effect
of ICAP-1 on cell spreading on extracellular matrix proteins,
but their observation is consistent with our finding that
ICAP-1 reduces cell spreading.
Based on tests detecting effector protein activation, such
as p21PAK and ACK2, it has been proposed that cell matrix
adhesion causes rapid and transient activation of Cdc42 and
Rac1 (Price et al., 1998; Yang et al., 1999). On the other
hand, during the initial phase of cell spreading RhoA activity
is not increased (Ren et al., 1999) and might be even inhib-
ited via a src-p190RhoGAP pathway (Arthur et al., 2000).
Although Cdc42 and Rac1 stimulate actin polymerization
and assembly of protrusive membrane structures, such as
filopodia and lamellipodia, necessary for cell spreading and
locomotion on the substratum, RhoA is known to promote
actin filament assembly in stress fibers and to increase the
contractile forces exerted by the actomyosin filaments
(Schoenwaelder and Burridge, 1999). Thus, it has been pro-
posed that inhibition of RhoA during initial phases of cell
spreading is necessary to prevent contractile forces that
would interfere with the highly dynamic actin-based activity
occurring at membrane protrusions during cell adhesion or
migration.
Here, by directly measuring GTP-bound forms we show
that adhesion to fibronectin induces activation of Cdc42
and Rac1. Moreover, we report that ICAP-1 binds to both
Cdc42 and Rac1 and prevents their activation along with
cell spreading. Interestingly, RhoA binds very poorly to
ICAP-1 and is not significantly activated during cell adhe-
sion to fibronectin under the experimental conditions used.
In addition, the activation state of RhoA triggered by the
GEF protein Dbl or LPA treatment is not affected by ICAP-1
expression. Together, these data suggest that ICAP-1 acts as
specific regulator of Cdc42 and Rac1 GTPases during the
initial phases of cell spreading on extracellular matrix pro-
tein.
Rho family GTPases are covalently modified by isopreny-
lation that is required for their translocation from the cyto-
sol to the cellular membrane where they perform their func-
tion (Van Aelst and D’Souza-Schorey, 1997). On the other
hand, through their isoprenoid moiety these GTPases can
interact with GDI molecules that keep them in an inactive
Figure 7. ICAP-1 stimulated release of Cdc42 from the membranes of 
COS cells. Membranes from COS cells transfected with myc-Cdc42 
were prepared as described in Materials and methods. The mem-
branes were incubated with the indicated amounts of purified 
MBP–ICAP-1 or MBP alone as a control for 25 min at room 
temperature. After centrifugation, the supernatant fractions were 
examined for the presence of Cdc42 using SDS-PAGE and Western 
blotting with a specific antibody (A). The relative amount of Cdc42 
released into supernatant fraction was determined by densitometric 
scanning analysis (B). 
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cytoplasmic pool (Regazzi et al., 1992). Interestingly, we
found that addition of purified ICAP-1 to a membrane frac-
tion induces the release of membrane-bound Cdc42 and
that ICAP-1 is able to reduce the release of the guanine nu-
cleotide from Cdc42 in the presence of a known exchange
factor such as Dbl. In addition, ICAP-1 was found to bind
more strongly to Cdc42 isolated from the membrane frac-
tion than to cytosolic Cdc42 or Cdc42 synthesized in
prokaryotic cells where the GTPases cannot be isopreny-
lated. These properties support the idea that ICAP-1 exert a
GDI activity. In our assay conditions, this activity was lower
than that of RhoGDI, suggesting that ICAP-1 has distinct
and unique properties from a previously characterized GDI.
We can hypothesize that ICAP-1 acts only on the limited
pool of Cdc42 and Rac1 involved in the turnover of new
contact sites, spatially restricted to filopodia and lamellipo-
dia during spreading or migration processes, whereas the re-
maining pool of Cdc42 could be regulated by other GDI
molecules such as RhoGDI.
Interestingly, comparative sequence analysis indicated an
overall homology of 27% between ICAP-1 and RhoGDI
(Fig. 8) and several other members of the GDI family (un-
published data). The homology was particularly striking
(34%) in the COOH terminal region spanning from resi-
dues 80 to 200. As shown by Hoffman et al. (2000), this re-
gion of RhoGDI consists of an immunoglobulin-like do-
main that binds to the isoprenyl moiety of the GTPase.
More interestingly, 60% of the RhoGDI residues shown to
be crucial for this interaction (Fig. 8, gray shaded residues)
are conserved in the corresponding region of ICAP-1. More-
over, the predicted secondary structure of this region of
ICAP-1 is significantly similar to the one determined by
crystallography for the RhoGDI as shown in Fig. 8 (Hoff-
man et al., 2000). Thus, these structural homologies are
consistent with the ability of ICAP-1 to bind Cdc42 and re-
lease it from the membrane. In addition, the amino acid res-
idues 45 and 47 in RhoGDI (Fig. 8) crucial for the GDI ac-
tivity and conserved in several GDI molecules are also
conserved in ICAP-1 (Fig. 8).
At present, we do not know whether ICAP-1 has a GDI
activity on Rac1, and we cannot definitively conclude
whether the inhibition of Rac1 observed with the pull-down
PAK assay is due to a direct GDI activity on this GTPase. It
is also possible that Rac1 is inhibited as a consequence of
Cdc42 inhibition by ICAP-1. It has been proposed that
these GTPases can act in cascade, Cdc42 being able to acti-
vate Rac1 (Nobes and Hall, 1995). However, the ability of
ICAP-1 to bind Rac1 suggests that ICAP-1 should directly
affect Rac1 activity. Further studies are necessary to precisely
define the detailed mechanisms of ICAP-1 function on Rac.
Previous work has shown that integrins can regulate GEF
function. GEFs are proteins capable of stimulating the ex-
change of GDP with GTP, thus increasing the active GTP-
bound form of the GTPases. In particular, two GEF mole-
cules, Vav1 and cytohesin1, can be regulated in response to
cell matrix adhesion. Vav1 is an exchange factor for Rac1
that can be activated by tyrosine phosphorylation (Crespo et
al., 1997). Indeed, integrin-mediated cell adhesion was
shown to induce Vav1 tyrosine phosphorylation in different
cell types (Cichowski et al., 1996; Gotoh et al., 1997;
Miranti et al., 1998; Yron et al., 1999). Cytohesin1 is a GEF
for ARF, a GTPase known to be involved in the regulation
of vesicle traffic in the secretory/endocytic pathway. Recent
results have shown that cytohesin1 is crucial in regulating
integrin affinity state for the extracellular ligand, a process
known as inside/out signaling (Geiger et al., 2000). Both
Vav1 and cytohesin1 are expressed preferentially in he-
mopoietic cell lineages and are likely to play a major role in
this system. Another GEF protein that is likely to play a role
in integrin-mediated activation of Cdc42 and Rac1 is PIX
(Turner et al., 1999). This protein is part of a large complex
that includes PAK, NCK, p95PKL, and paxillin. The im-
portant role played by paxillin in cell adhesion, and the lo-
calization of this complex at focal adhesions (Turner et al.,
1999) strongly argues for an important role of PIX as a
downstream effector in integrin-mediated actin cytoskeleton
organization.
The existence of a GDI protein, like ICAP-1, in the path-
way of integrin signaling suggests that during cell matrix ad-
hesion not only GEF should be activated in order to increase
the GTP-bound form of the GTPases, but the inhibitory ac-
tion of the GDI molecule should be released. A hypothetical
Figure 8. Sequence alignment of 
bovine RhoGDI (RhoGDIBt) and ICAP-1 
proteins. Sequences of human ICAP-1 
(sequence data available from GenBank/
EMBL/DDBJ under accession no. 
NP_004754) and bovine RhoGDI 
(accession no. CAA36916) were 
aligned using CLUSTAL W (1.81). Lines 
above RhoGDIBt sequence indicate 
secondary structure elements as 
reported by Hoffman et al. (2000). Lines 
under ICAP-1A sequence indicate a 
prediction of its secondary structure 
elements as obtained using a Biology 
Work Bench protein analysis tool based 
on the DSC algorithm (King and Sternberg, 
1990). Shaded grey areas indicate 
residues of the RhoGDIBt that interact with Cdc42 geranylgeranyl moiety. Asterisks indicate single fully conserved residue. Colons 
indicate conservation of strong groups. Periods indicate conservation of weak groups. 
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model can be envisaged in which in cells detached from the
matrix, ICAP-1 forms an inhibitory complex with Cdc42 by
displacing it from the plasma membrane and preventing the
exchange of the GDP for the GTP. Upon interaction with
extracellular matrix, ICAP-1 is modified to neutralize its
GDI activity. Indeed, it has been shown that ICAP-1 is
phosphorylated upon integrin-mediated cell adhesion to fi-
bronectin (Chang et al., 1997; Zhang and Hemler, 1999),
and it can thus be postulated that this event affects the GDI
activity of the protein. In the experimental system used here,
ICAP-1 levels are increased several fold over the basal level
in consequence of transfection, and thus its inhibition of
the Rho family GTPases persists for longer times, causing
the delay in cell spreading. The functional significance of
ICAP-1 binding to the 
 
 
 
1-integrin cytoplasmic domain is
still to be defined. It is possible that ICAP-1 binds to the in-
tegrin cytoplasmic domain to perform other functions such
as regulation of integrin affinity as proposed by Block and
coworkers (Bouvard and Block, 1998). Indeed, we did not
observe any difference in ICAP-1 effect on cell spreading us-
ing two distinct extracellular matrix substrates, such as fi-
bronectin and vitronectin, suggesting that the potential 
 
 
 
1
 
A
integrin-mediated control of ICAP-1 function was overcome
due to ICAP-1 overexpression levels. However, overexpres-
sion approach led us to bring to light the important function
of ICAP-1 as a GDI molecule.
Furthermore, ICAP-1 specifically binds to the 
 
 
 
1A iso-
form in the COOH terminal region known to differ among
the splicing isoforms (Balzac et al., 1994; Fornaro et al.,
1995; Belkin et al., 1996). Binding involves the more
COOH terminal NPXY motive present in 
 
 
 
1A integrin cy-
toplasmic domain (Chang et al., 1997) and residues imme-
diately upstream (Table I). Interestingly, two isoforms of the
 
 
 
1 integrin, 
 
 
 
1B and 
 
 
 
1D, that do not bind ICAP-1 are in-
competent to support cell spreading and cell migration on
fibronectin (Balzac et al., 1994; Belkin et al., 1997). These
properties are consistent with the hypothesis that binding of
ICAP-1 to 
 
 
 
1 integrin is required to release the inhibitory
effect of this protein on Cdc42 and Rac1, thus promoting
cell spreading and migration. However, further work is nec-
essary to test this hypothesis.
In conclusion, the data reported here show that ICAP-1, a
protein isolated as an interactor of the 
 
 
 
1-integrin cytoplas-
mic domain, binds and negatively regulates Cdc42 and
Rac1, acting as a guanine nucleotide dissociation inhibitor.
Thus, this protein is a new element, potentially connecting
integrin-mediated cell matrix adhesion with regulation of
the actin cytoskeleton.
 
Materials and methods
 
Interaction trap
 
Screening for proteins that interact with cytoplasmic tails of 
 
 
 
1A was per-
formed as described (Gyuris et al.,1993). To construct the bait plasmid,
DNA sequence encoding amino acids 752–798 of 
 
 
 
1A was amplified
by PCR using primers containing EcoRI and BamHI sites on either ends
(
 
 
 
1A, 5
 
 
 
-GGAATTCAAGCTTTTAATGA4TAATT-3
 
 
 
 and 5
 
 
 
-CGGGATCCT-
CATTTTCCCTCATACTT-3
 
 
 
) and cloned in pEG 202 vector in frame with
LexA coding sequence. This plasmid was unable to activate transcription
when cotransformed in EGY48 yeast strain with pSH 18–34 reporter plas-
mid. The expression of this fusion protein in yeast total protein extracts
was confirmed by Western blot analysis using an anti-LexA antibody (a gift
 
from A. Zervos, University of Central Florida, Orlando, FL). A cDNA li-
brary from heart neonatal rat fused to a galactose-inducible activation do-
main (a gift from A. Zervos) was transformed in yeast strain EGY48 that al-
ready contained pSH 18–34 reporter plasmid and pEG202-
 
 
 
1A using a
LiAc high efficiency transformation protocol (Gietz et al., 1992). Primary
transformants (2 
 
 
 
 10
 
6
 
) were screened by plating 10
 
7
 
 colonies on select-
able medium lacking Ura, His, Trp, and Leu. Several positive clones were
isolated, and their specific binding to integrins was tested by assaying the
interaction with control baits such as bicoid, bFGF, cyclin A, and c-Myc (a
gift from A. Zervos).
Other baits were produced to test the ability of ICAP-1 to interact with
other integrin cytoplasmic tails. These baits were prepared by PCR amplifi-
cation using the following primers: (5
 
 
 
-catgccatggaaggctctgatccacctg-3
 
 
 
 and
5
 
 
 
ccgctcgagctaactctcagcaaactt-3
 
 
 
) coding for amino acid residues 724–769
of 
 
 
 
2; (5
 
 
 
-gcatgccatggaaactcctcatcaccatc-3
 
 
 
 and 5
 
 
 
-ccgctcgagttaagtgccccg-
gtacgt-3
 
 
 
) coding for amino acid residues 716–762 of human 
 
 
 
3; (5
 
 
 
-ggaat-
tcaagcttttaatgataatt-3
 
 
 
 and 5
 
 
 
-cgggatccttataagccactttgctt-3
 
 
 
) coding for
amino acid residues 752–789 of 
 
 
 
1B; (5
 
 
 
-ggaattcaagcttttaatgataatt-3
 
 
 
 and
5
 
 
 
-cgggatcctcagagaccagctttacg-3
 
 
 
) coding for amino acid residues 752–801
of 
 
 
 
1D; and (5
 
 
 
-ggaattcaagcttggattcttcaaa-3
 
 
 
 and 5
 
 
 
-cgggatcctcaggcatcagag-
gtggc-3
 
 
 
) coding for amino acid residues 1022–1049 of 
 
 
 
5.
To map the ICAP-1 binding site in 
 
 
 
1A, four swapping mutant con-
structs of 
 
 
 
1A and 
 
 
 
1D cytoplasmic regions were generated by PCR ampli-
fication and cloned in frame with LexA sequence in pEG 202. The follow-
ing mutants were generated: 
 
 
 
1A/D (A778–795/D796–801), 
 
 
 
1D/A
(D778–795/A796–798), 
 
 
 
1A/D/A (A778–785/D786–791/A792–798), and
 
 
 
1D/A/D (D778–785/A786–791/D792–801). Numbers indicate the amino
acid residues in the cytoplasmic region of 
 
 
 
1A and 
 
 
 
1D (Table I).
 
Constructs and antibodies
 
Positive clones selected with the two-hybrid screening were sequenced us-
ing ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction kit
(PerkinElmer). A10-1 cDNA fragment contained the sequence of ICAP-1
lacking a 5
 
  
 
fragment coding for the first 12 amino acids of the protein. The
full length of ICAP-1 was constructed by PCR amplification. A10.1 clone
was used as template and annealed to a synthetic oligonucleotide coding
for the first 12 missing amino acids of the protein. The coding sequence
was obtained from the mouse ICAP-1 cDNA (Faisst and Gruss, 1998). A
second cycle of PCR amplification was made to introduce a myc tag and
KpnI restriction site. The PCR products were digested with KpnI and XhoI
and inserted into pcDNA3 eukaryotic expression vector.
To produce large amounts of soluble protein, the full-length ICAP-1 was
fused to maltose binding protein for expression in prokaryotic cells. Using
pcDNA3-myc–ICAP-1 as template, EcoRI restriction enzyme site was in-
troduced by PCR amplification in ICAP-1 full-length cDNA. The fragment
was cloned into the EcoRI/XbaI sites of pMAL-p2 vector. All constructs
were sequenced using ABI PRISM Big Dye Terminator Cycle Sequencing
Ready Reaction kit.
The following prokaryotic expression constructs were used to express
GST fusion proteins: pGEX PAK-CD, encoding the PAK-CRIB, was pro-
vided by J. Collard (Netherland Cancer Institute, Amsterdam, Netherlands)
(Sander et al., 1998). pGEX RhoGDI was provided by Y. Zheng (University
of Tennessee, Memphis, TN) (Leonard et al., 1992). pGEX-Cdc42 was pro-
vided by R. Cerione (Cornell University, Ithaca, NY). PGEX-mDIA was pro-
vided by S. Narumiya (Kyoto University, Kyoto, Japan).
To express GST fusion proteins in eukaryotic cells, Cdc42Hs cDNA and
cDNA coding for Dbl DH/PH domains (residues 497–875) were cloned
into the BamHI site of the pCEFL-GST vector provided by S. Gutkind (Na-
tional Institutes of Health, Bethesda, MD).
pcEXV-myc-V12Cdc42, pRK5-myc-Cdc42, and pRK5-mycRac1 con-
structs, a gift from A. Hall (University College of London, London, UK),
were used for transient expression in NIH3T3 and COS cells.
Polyclonal rabbit antiserum against ICAP-1 was prepared by immuniz-
ing a rabbit with MBP–ICAP-1 fusion protein.
Antibodies against Cdc42 and RhoA were purchased from Santa Cruz
Biotechnology, Inc. 9E10 anti-myc monoclonal antibody was purchased
from Sigma-Aldrich. Anti-Rac1 monoclonal antibody was purchased from
Upstate Biotechnology.
 
Cell cultures and transfection
 
COS cells cultured in DME supplemented with 10% FCS were transiently
transfected at 80% confluence by the DEAE-dextran method (Kluxen and
Lubbert, 1993) and used for experiments 48 h after DNA addition.
NIH3T3 fibroblasts were cultured in DME supplemented with 10% calf
serum. For Immunofluorescence experiments, cells were plated at a den-
sity of 12
 
 
 
10
 
4
 
 into 6-well culture plates and transfected with 10 
 
 
 
g of 
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plasmid DNA using the calcium phosphate procedure (Chen and
Okayama, 1987). In cotransfection experiments, the various DNA con-
structs were used at a 1:1 ratio. Cells were used for experiments 36 h after
DNA addition.
To obtain stable expression of V12Cdc42, NIH3T3 were transfected
with pZipNeo-V12Cdc42 by the calcium phosphate procedure and grown
for 3 wk in the presence of 375 
 
 
 
g/ml G418 as described (Olivo et al.,
2000).
 
Immunofluorescence analysis
 
Transiently transfected cells were detached gently with 5 mM EDTA in
PBS, washed with PBS containing 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, and plated in
serum-free DME for 1 h onto fibronectin-coated coverslips. Cells were
fixed in 3% paraformaldehyde for 10 min and permeabilized with 0.5%
Triton X-100/TBS (150 mM NaCl, 50 mM Tris-HCl, pH 7.4) for 1 min.
F-actin was revealed by staining with fluorescein-FITC-phalloidin (Sigma-
Aldrich). Transiently transfected cells were revealed with anti-myc mono-
clonal antibody 9E10. Cells were observed and counted under an Olym-
pus fluorescence microscope, and pictures were taken with an Olympus
DP10 digital photomicrography system. To evaluate the degree of cell
spreading, the cell area was measured by a computerized image analysis
system. Cells with an area 
 
 
 
150 
 
 
 
m
 
2
 
 were considered spread.
 
Rho GTPases activity assays
 
The assay described by Sander et al. (1998) based on the interaction of the
GTP-bound GTPase to the PAK CRIB domain was used. To prepare the
GST-PAK CRIB domain fusion protein, 
 
Escherichia coli
 
 TOPF
 
1 
 
10 cells
transformed with the GST-PAK-CD construct were harvested and resus-
pended in lysis buffer (50 mM Tris-Hcl, pH 7.5, 1 mM EDTA, 100 mM
NaCl, 5% glycerol, 0.1% Triton X-100, 1 mM DTT, 10 
 
 
 
g/ml leupeptin,
0.4 
 
 
 
g/ml pepstatin, 0.1 TIU/ml aprotinin, 1 mM PMSF) and sonicated. Af-
ter centrifugation, the cell lysate supernatant was incubated with glu-
tathione-coupled Sepharose 4B beads (Amersham Pharmacia Biotech) for
30 min at 4
 
 
 
C. The beads were washed three times in lysis buffer, and the
amount of bound fusion protein was estimated after separation by SDS-
PAGE and Coomassie blue staining.
COS cells transiently transfected with the indicated constructs were de-
tached with trypsin-EDTA (0.05% trypsin, 0.02% EDTA in PBS), washed
twice with serum-free DME, and maintained in suspension for 2 h 30 min
at 4
 
 
 
C in serum free DME before plating on coated dishes. 1 h after seed-
ing, the cells were washed in ice-cold PBS, incubated 5 min on ice in lysis
buffer (50 mM Tris-HCl, pH 7.4, 2 mM MgCl
 
2
 
, 100 mM NaCl, 10% glyc-
erol, 1% NP-40, 10 
 
 
 
g/ml leupeptin, 0.4 
 
 
 
g/ml pepstatin, 0.1 TIU/ml apro-
tinin, 1 mM PMSF), and then centrifuged for 5 min at 4
 
 
 
C at 16,000 
 
g
 
. Ali-
quots were taken from the supernatant to compare protein amounts. The
supernatant was incubated with GST-PAK-CD bound to glutathione–
Sepharose beads (Amersham Pharmacia Biotech) at 4
 
 
 
C for 30 min. The
beads were washed three times with an excess of lysis buffer, and bound
proteins were eluted in Laemmli sample buffer and analyzed for the pres-
ence of Cdc42 or Rac1 molecules by Western blotting using antibodies
specific for Cdc42 and Rac.
Rho activation state was assessed by using GST-mDIA fusion protein to
pull down GTP-loaded RhoA accordingly with Kimura et al. (2000).
 
Affinity chromatography
 
To prepare the affinity matrix, ICAP-1 was expressed as a MBP fusion pro-
tein and purified from 
 
E. coli 
 
by affinity chromatography on amilose resin
(Biolabs). 5 mg of purified MBP–ICAP-1 or MBP alone as control were dia-
lyzed overnight at 4
 
 
 
C in coupling buffer (0.1 M NaHCO
 
3
 
/Na
 
2
 
CO
 
3
 
, pH
9.2) and incubated for 2 h at room temperature with 430 mg of dried
CNBr-activated Sepharose 4B (Amersham Pharmacia Biotech).
Cdc42-containing cell extracts were prepared by expressing the GST–
Cdc42 fusion protein in 
 
E. coli
 
 and in COS cells using pGEX-Cdc42 and
pCEFL-GST-Cdc42 constructs, respectively. Transfected COS cells were
lysed with 50 mM Tris-HCl, pH 7.4, 2 mM MgCl
 
2
 
, 100 mM NaCl, 10%
glycerol, 1% NP-40, 10 
 
 
 
g/ml leupeptin, 4 
 
 
 
g/ml pepstatin, 0.1 TIU/ml
aprotinin, and 1 mM PMSF. After centrifugation at 10,000 
 
g
 
, total soluble
proteins were chromatographed on MBP–ICAP-1 Sepharose. After washing
with five volumes of TBS, the proteins were eluted with 0.1 M glycine-
HCl, pH 3. The collected fractions (500  l each) were neutralized by titra-
tion with 1.5 M Tris-HCl, pH 8.8, lyophilized, and analyzed by SDS-PAGE
and Western blotting with polyclonal rabbit antibody against Cdc42.
To compare the binding capacity to ICAP-1 of the membrane-bound cy-
tosolic or E. coli produced Cdc42 extracts from cytoplasmic and mem-
brane fractions of COS cells (see below for membrane fraction prepara-
tion) or bacterial lysates were loaded on the MBP–ICAP-1 Sepharose
column. Columns were loaded with equal amounts of Cdc42 as deter-
mined by Western blotting. To test if the binding activity of the GTPases to
ICAP-1 was affected by the nature of the bound guanine nucleotide, the
procedure described by Hart et al. (1994) was followed.
To test ICAP-1 binding to Rac1 and RhoA, total extracts of COS cells
were used in the affinity chromatography procedure described above, and
the eluted proteins were analyzed by Western blotting with specific mono-
clonal antibodies.
Assay of GDP dissociation from Cdc42
The release of GDP from Cdc42 was measured as described (Leonard et
al., 1992).
To purify the isoprenylated form of Cdc42, a construct encoding for the
GST-Cdc42 fusion protein (pCEFL-GST-Cdc42) was transfected in COS
cells. 48 h after transfection, 4 10
7 cells were trypsinized, washed with
PBS, and lysed in hypotonic lysis buffer (20 mM Tris-HCl, pH 8, 1 mM
EDTA, 1 mM DTT, 1 mM PMSF, 0.1 TIU aprotinin, 10  g/ml leupeptin, 4
 g/ml pepstatin) with 20 strokes of a 7-ml glass/glass Dounce homoge-
nizer. Homogenates were centrifuged at 10,0000 g for 1 h, the cytosol-
containing supernatant was removed, and the crude membrane pellet was
solubilized with TBS containing 1% Triton X-100, 10  g/ml leupeptin, 4
 g/ml pepstatin, 0.1 TIU/ml aprotinin, and 1 mM PMSF for 90 min at 4 C
and then clarified by centrifugation at 10,0000 g for 1 h. The solubilized
membrane fraction was incubated with glutathione-coupled Sepharose
beads at 4 C for 30 min. The beads were then washed three times with
PBS, and the amount of bound fusion protein was estimated using Coo-
massie-stained SDS gels.
To load Cdc42 with a radiolabeled nucleotide, the beads were first in-
cubated with 20 mM Tris-HCl, pH 8, 50 mM NaCl, 100  M AMP-PNP,
100  M DTT, 2 mM MgCl2, and 0.7  M [ -
32P]GTP for 25 min at room
temperature and washed extensively in the same buffer to remove un-
bound radiolabeled nucleotide. Aliquots (5  l) of guanine nucleotide–
loaded Cdc42 bound to the beads (typically 200–300 ng in 5  l) were in-
cubated with 20  l of 50 mM Tris-HCl, pH 7.5, 1 mM DTT, 1 mM EDTA,
and 2 mM MgCl2, containing purified proteins (MBP, MBP–ICAP-1, GST-
RhoGDI, GST-Dbl/DH-PH), or the buffer alone and were allowed to incu-
bate for an additional 10 min at room temperature. To induce the release
of the GDP, 32  l of GDI buffer (55 mM Tris-HCl, pH 7.5, 45 mM NaCl, 1
mM AMP-PNP, 100  M DTT, 5 mM EDTA, 1 mM GDP, 0.55 mg/ml BSA)
were added to each sample. After the indicated time of incubation at room
temperature, the reaction was stopped by diluting the samples in 1.8 ml of
ice-cold buffer containing 20 mM Tris-HCl, pH 8, 100 mM NaCl, and 10
mM MgCl2, washed three times with the same buffer, and analyzed in the
  counter. When the dissociation of the GDP was measured in the pres-
ence of 100 ng of the GEF GST-Dbl, the assays were performed essentially
as outlined above except that EDTA was omitted and 2 mM MgCl2 was
added to the GDI buffer.
RhoGDI was expressed as a GST fusion protein from pGEX vector and
purified from E. coli using glutathione–Sepharose 4B column. GST-Dbl
(DH-PH domain) was transfected in COS cells and purified using glu-
tathione–Sepharose 4B column.
Release of Cdc42 protein from COS cell membranes
Adherent COS cells were transfected with pRK5-myc-Cdc42 construct as
described above. Transfected cells were frozen in liquid nitrogen and
thawed in 10 ml hypotonic buffer consisting of 20 mM Tris-HCl, pH 8, 6
mM EDTA, 1 mM DTT, 1 mM PMSF, 0.1 TIU aprotinin, 10  g/ml leupep-
tin, 4  g/ml pepstatin, and lysed with 10 strokes of a 7-ml glass/glass
Dounce homogenizer. The nuclei and any unbroken cells were removed
from the sample by centrifugation at 1,000 g for 12 min. The supernatant
was centrifuged at 27,000 g for 10 min at 4 C to pellet the particulate frac-
tion. After removal of the supernatant, the membranes were washed twice
in hypotonic buffer, resuspended in 1.5 ml of 20 mM Tris-HCl, 1 mM
EDTA, 1 mM DTT, pH 8, and aliquoted for long-term storage at –80 C.
A 10- l aliquot of membrane fraction was mixed with 8  l of reaction
buffer (100 mM Tris-HCl, 250 mM NaCl, 25 mM MgCl2, pH 8) and 22  l
of distilled H2O containing increasing amounts of purified MBP–ICAP-1 or
MBP as negative control. This mixture was incubated at room temperature
for 25 min and then centrifuged at 27,000 g for 10 min at 4 C to separate
the membranes from the soluble fraction. The supernatant and the pellet
were then analyzed by SDS-PAGE and Western blotting with polyclonal
rabbit antibody against Cdc42. The relative amount of Cdc42 was deter-
mined by densitometric scanning analysis.
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